These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1080 related articles for article (PubMed ID: 26176088)
21. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Ma S; Shen L; Qian N; Chen K Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301 [TBL] [Abstract][Full Text] [Related]
22. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. Tachibana M; Takemoto Y; Nakashima Y; Kinugasa S; Kotoh T; Dhar DK; Kohno H; Nagasue N J Am Coll Surg; 1998 Jul; 187(1):64-8. PubMed ID: 9660027 [TBL] [Abstract][Full Text] [Related]
23. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging? Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670 [TBL] [Abstract][Full Text] [Related]
24. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Li F; Li S; Wei L; Liang X; Zhang H; Liu J Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812 [TBL] [Abstract][Full Text] [Related]
25. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer. Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155 [TBL] [Abstract][Full Text] [Related]
26. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Marrelli D; Roviello F; De Stefano A; Farnetani M; Garosi L; Messano A; Pinto E Oncology; 1999 Jul; 57(1):55-62. PubMed ID: 10394126 [TBL] [Abstract][Full Text] [Related]
28. Investigation of serum tumor markers in the diagnosis of gastric cancer. Fan B; Xiong B Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322 [TBL] [Abstract][Full Text] [Related]
29. Prognostic values of normal preoperative serum cancer markers for gastric cancer. Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455 [TBL] [Abstract][Full Text] [Related]
30. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614 [TBL] [Abstract][Full Text] [Related]
31. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Li Y; Yang Y; Lu M; Shen L Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer]. Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529 [TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Shimada H; Noie T; Ohashi M; Oba K; Takahashi Y Gastric Cancer; 2014 Jan; 17(1):26-33. PubMed ID: 23572188 [TBL] [Abstract][Full Text] [Related]
35. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Mattar R; Alves de Andrade CR; DiFavero GM; Gama-Rodrigues JJ; Laudanna AA Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(3):89-92. PubMed ID: 12118264 [TBL] [Abstract][Full Text] [Related]
36. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055 [TBL] [Abstract][Full Text] [Related]
37. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
38. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma. Ikeguchi M; Katano K; Saitou H; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1997; 44(15):866-71. PubMed ID: 9222706 [TBL] [Abstract][Full Text] [Related]
39. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279 [TBL] [Abstract][Full Text] [Related]
40. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study. Distler M; Pilarsky E; Kersting S; Grützmann R Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]